arrow_back Back to App

Fair Prescription Drug Prices Act: Capping Drug Costs for Americans

This act aims to lower prescription drug prices in the United States. It introduces a price cap, ensuring that drug prices cannot exceed the average price of the same drugs in selected developed countries. This could lead to lower out-of-pocket costs for citizens, impacting their personal finances and access to healthcare.
Key points
Prescription drug prices in the U.S. cannot exceed the average price in Canada, France, Germany, Italy, Japan, and the United Kingdom.
Pharmaceutical companies violating this cap will face significant financial penalties.
The government will annually calculate average drug prices in these countries to enforce the new rules.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1587
Sponsor: Sen. Hawley, Josh [R-MO]
Process start date: 2025-05-05
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fair Prescription Drug Prices for Americans Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1587.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-05.

What are the main provisions?

Key points include:

  • Prescription drug prices in the U.S. cannot exceed the average price in Canada, France, Germany, Italy, Japan, and the United Kingdom.
  • Pharmaceutical companies violating this cap will face significant financial penalties.
  • The government will annually calculate average drug prices in these countries to enforce the new rules.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hawley, Josh [R-MO].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health